                         SEQUENCE LISTING

<110>  Antisense Therapeutics Ltd
 
<120>  Methods for Treating Multiple Sclerosis using Antisense 
       Oligonucleotide

<130>  525815PCT

<150>  2017902314
<151>  2017-06-16

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  Chemically synthesized


<220>
<221>  2'-O-(2-methoxyethyl) 5-methylcytosine
<222>  (1)..(1)

<220>
<221>  2'-O-(2-methoxyethyl) modified ribonucleosides
<222>  (1)..(3)

<220>
<221>  2'-O-(2-methoxyethyl) 5-methyluracil
<222>  (2)..(2)

<220>
<221>  2'-deoxyribonucleosides
<222>  (4)..(12)

<220>
<221>  2'-deoyxy 5-methylcytosine
<222>  (7)..(7)

<220>
<221>  2'-O-(2-methoxyethyl) modified ribonucleosides
<222>  (13)..(20)

<220>
<221>  2'-O-(2-methoxyethyl)  5-methyluracil
<222>  (13)..(13)

<220>
<221>  2'-O-(2-methoxyethyl) 5-methylcytosine
<222>  (14)..(15)

<220>
<221>  2'-O-(2-methoxyethyl) 5-methyluracil
<222>  (17)..(18)

<220>
<221>  2'-O-(2-methoxyethyl) 5-methycytosine
<222>  (19)..(19)

<220>
<221>  2'-O-(2-methoxyethyl) 5-methyuracil
<222>  (20)..(20)

<400>  1
cugagtctgt ttuccauucu                                                   20


